Multilex Clinical Modules

Select a Screening & Detection Module:

Drug-Drug Interaction Module™

Identifying and preventing clinically-significant drug interactions.

The Drug-Drug Interaction Module helps clinicians identify and prevent clinically-significant drug interactions. It includes drug interaction information for prescription drugs, OTC drugs, alternative therapies, and inactive ingredients. Management of alerts is achieved through superior configurability; by offering specific categories of interactions, users can fine tune alerts using severity levels and subcategories such as “conflicting evidence exists.”

FDB Drug-Drug Interaction Module Advantages:

  • Presents highly flexible drug-drug interaction severity levels and filtering parameters and offers flexible ways for developers to create applications that categorize and display potentially harmful drug-drug interactions. These drug interactions are separated into highly granular categories, which help in managing message overload.
  • Identifies the type of evidence available for each drug interaction, such as animal study or human clinical trial, allowing further choice in how a system or institution treats interaction groupings.
  • Includes documented drug-alternative therapy interactions. In addition to three interaction severity levels and numerous "clinical effects" sub-categories, this module includes a category for alternative therapy agents, such as herbals and dietary supplements.
  • Incorporates Professional Drug-Interaction Monographs that refer to the primary medical literature and government-approved prescribing information. Each section is coded to allow users to access the entire drug interaction monograph, or just specific sections.
  • A consumer version of this module, Drug-Drug Interaction for Consumers, is also available.